The impact of equol-producing status in modifying the effect of soya isoflavones on risk factors for CHD: a systematic review of randomised controlled trials

Recent studies suggest that the ability to produce equol, a metabolite of the soya isoflavone daidzein, is beneficial to coronary health. Equol, generated by bacterial action on isoflavones in the human gut, is biologically more potent than dietary sources of isoflavones. Not all humans are equol pr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Nutr Sci
Autors principals: Birru, Rahel L., Ahuja, Vasudha, Vishnu, Abhishek, Evans, Rhobert W., Miyamoto, Yoshihiro, Miura, Katsuyuki, Usui, Takeshi, Sekikawa, Akira
Format: Artigo
Idioma:Inglês
Publicat: Cambridge University Press 2016
Matèries:
Systematic Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4976117/
https://ncbi.nlm.nih.gov/pubmed/27547393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/jns.2016.18
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars